• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 3-氯-6-硝基-1-吲唑衍生物作为有前途的抗利什曼原虫候选物:合成、生物活性和分子模拟研究。

Novel 3-chloro-6-nitro-1-indazole derivatives as promising antileishmanial candidates: synthesis, biological activity, and molecular modelling studies.

机构信息

Laboratoire de Chimie Organique Hétérocyclique, Centre de Recherche des Sciences des Médicaments, Pôle de Compétences Pharmacochimie, URAC 21, Faculté des Sciences, Mohammed V University Rabat, Rabat, Morocco.

Department of Theoretical and Applied Chemistry, South Ural State University, Chelyabinsk, Russia.

出版信息

J Enzyme Inhib Med Chem. 2022 Dec;37(1):151-167. doi: 10.1080/14756366.2021.1995380.

DOI:10.1080/14756366.2021.1995380
PMID:34894940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8667887/
Abstract

An efficient pathway was disclosed for the synthesis of 3-chloro-6-nitro-1-indazole derivatives by 1,3-dipolar cycloaddition on dipolarophile compounds and . Faced the problem of separation of two regioisomers, a click chemistry method has allowed us to obtain regioisomers of triazole-1,4 with good yields from 82 to 90% were employed. Also, the antileishmanial biological potency of the compounds was achieved using an MTT assay that reported compound as a promising growth inhibitor of . Molecular docking demonstrated highly stable binding with the Leishmania trypanothione reductase enzyme and produced a network of hydrophobic and hydrophilic interactions. Molecular dynamics simulations were performed for TryR- complex to understand its structural and intermolecular affinity stability in a biological environment. The studied complex remained in good equilibrium with a structure deviation of ∼1-3 Å. MM/GBSA binding free energies illustrated the high stability of TryR- complex. The studied compounds are promising leads for structural optimisation to enhance the antileishmanial activity.

摘要

揭示了一条通过 1,3-偶极环加成反应在双烯和亲偶极体化合物上合成 3-氯-6-硝基-1-吲唑衍生物的有效途径。面对两种区域异构体分离的问题,点击化学方法使我们能够从 82%到 90%的产率获得具有良好产率的三唑-1,4 区域异构体。此外,采用 MTT 测定法测定了化合物的抗利什曼原虫生物活性,报告化合物 是利什曼原虫硫醇还原酶的有前途的生长抑制剂。分子对接表明与 Leishmania trypanothione reductase 酶具有高度稳定的结合,并产生了疏水和亲水相互作用的网络。对 TryR-复合物进行了分子动力学模拟,以了解其在生物环境中的结构和分子间亲和力稳定性。研究的复合物在结构偏差约为 1-3 Å 的情况下保持良好的平衡。MM/GBSA 结合自由能说明了 TryR-复合物的高稳定性。研究的化合物是结构优化的有希望的先导化合物,以增强抗利什曼原虫活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/a64f8779e7ae/IENZ_A_1995380_F0013b_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/19fd7b613c66/IENZ_A_1995380_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/622bdaff5e86/IENZ_A_1995380_SCH0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/7abc0d433413/IENZ_A_1995380_SCH0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/869f70c3016b/IENZ_A_1995380_SCH0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/cffa31cfcbd6/IENZ_A_1995380_SCH0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/d51e9c7852e9/IENZ_A_1995380_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/02c56a0a02d0/IENZ_A_1995380_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/8f37ae579d1f/IENZ_A_1995380_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/06123afb77bc/IENZ_A_1995380_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/69182a1b3502/IENZ_A_1995380_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/7507783ff694/IENZ_A_1995380_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/871c05831004/IENZ_A_1995380_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/59fce6eedccc/IENZ_A_1995380_F0008_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/dd8db430a6a6/IENZ_A_1995380_F0009_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/614a1c670cd9/IENZ_A_1995380_F0010_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/55df79aeefe0/IENZ_A_1995380_F0011_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/9e3e2a87d359/IENZ_A_1995380_F0012_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/85ffc3d1bced/IENZ_A_1995380_F0013a_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/a64f8779e7ae/IENZ_A_1995380_F0013b_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/19fd7b613c66/IENZ_A_1995380_SCH0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/622bdaff5e86/IENZ_A_1995380_SCH0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/7abc0d433413/IENZ_A_1995380_SCH0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/869f70c3016b/IENZ_A_1995380_SCH0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/cffa31cfcbd6/IENZ_A_1995380_SCH0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/d51e9c7852e9/IENZ_A_1995380_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/02c56a0a02d0/IENZ_A_1995380_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/8f37ae579d1f/IENZ_A_1995380_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/06123afb77bc/IENZ_A_1995380_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/69182a1b3502/IENZ_A_1995380_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/7507783ff694/IENZ_A_1995380_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/871c05831004/IENZ_A_1995380_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/59fce6eedccc/IENZ_A_1995380_F0008_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/dd8db430a6a6/IENZ_A_1995380_F0009_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/614a1c670cd9/IENZ_A_1995380_F0010_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/55df79aeefe0/IENZ_A_1995380_F0011_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/9e3e2a87d359/IENZ_A_1995380_F0012_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/85ffc3d1bced/IENZ_A_1995380_F0013a_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a983/8667887/a64f8779e7ae/IENZ_A_1995380_F0013b_C.jpg

相似文献

1
Novel 3-chloro-6-nitro-1-indazole derivatives as promising antileishmanial candidates: synthesis, biological activity, and molecular modelling studies.新型 3-氯-6-硝基-1-吲唑衍生物作为有前途的抗利什曼原虫候选物:合成、生物活性和分子模拟研究。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):151-167. doi: 10.1080/14756366.2021.1995380.
2
Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.吩噻嗪和吩恶嗪衍生的氯乙酰胺对硕大利什曼原虫生长及布氏锥虫锥虫硫醇还原酶的抑制作用
Eur J Med Chem. 2016 Jan 27;108:436-443. doi: 10.1016/j.ejmech.2015.11.023. Epub 2015 Nov 23.
3
Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.新型噻唑嘧啶衍生物的设计、合成及体外生物学评价作为抗利什曼原虫化合物。
Arch Pharm (Weinheim). 2020 Aug;353(8):e1900325. doi: 10.1002/ardp.201900325. Epub 2020 Jun 2.
4
First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity.首例针对利什曼原虫双氢喋呤还原酶二聚体界面的肽类化合物,具有很强的抗利什曼原虫体外活性。
Eur J Med Chem. 2017 Jul 28;135:49-59. doi: 10.1016/j.ejmech.2017.04.020. Epub 2017 Apr 13.
5
Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography.基于唑类化合物对利什曼原虫硫氧还蛋白还原酶的抑制作用:X 射线晶体学与生理底物的比较分析。
ChemMedChem. 2013 Jul;8(7):1175-83. doi: 10.1002/cmdc.201300176. Epub 2013 Jun 3.
6
Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.基于金属的化合物作为潜在的抗利什曼原虫剂:特定金配合物对锥虫硫醇还原酶的抑制作用
ChemMedChem. 2013 Oct;8(10):1634-7. doi: 10.1002/cmdc.201300276. Epub 2013 Aug 23.
7
Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase.哒嗪并吡咯并喹喔啉鎓盐作为针对三磷酸鸟苷还原酶的高效且选择性的抗利什曼原虫药物。
Eur J Med Chem. 2022 Jan 5;227:113915. doi: 10.1016/j.ejmech.2021.113915. Epub 2021 Oct 15.
8
Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.基于结构的虚拟筛选、分子对接、ADMET和分子模拟,以开发苯并硼氧六环类似物作为杜氏利什曼原虫锥虫硫醇还原酶的潜在抑制剂。
J Recept Signal Transduct Res. 2017 Feb;37(1):60-70. doi: 10.3109/10799893.2016.1171344. Epub 2016 May 5.
9
Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents.新型杂芳基硒氰酸盐和二硒化物作为强效抗利什曼原虫剂
Antimicrob Agents Chemother. 2016 May 23;60(6):3802-12. doi: 10.1128/AAC.02529-15. Print 2016 Jun.
10
In silico molecular docking studies of new potential 4-phthalazinyl-hydrazones on selected Trypanosoma cruzi and Leishmania enzyme targets.新型潜在4-酞嗪基腙对所选克氏锥虫和利什曼原虫酶靶点的计算机辅助分子对接研究
J Mol Graph Model. 2017 Sep;76:313-329. doi: 10.1016/j.jmgm.2017.07.013. Epub 2017 Jul 19.

引用本文的文献

1
Indazole - an emerging privileged scaffold: synthesis and its biological significance.吲唑——一种新兴的优势骨架:合成及其生物学意义
RSC Med Chem. 2025 Aug 19. doi: 10.1039/d5md00336a.

本文引用的文献

1
Experimental spectral characterization, Hirshfeld surface analysis, DFT/TD-DFT calculations and docking studies of (2Z,5Z)-5-(4-nitrobenzylidene)-3-N(2-methoxyphenyl)-2-N'(2-methoxyphenylimino) thiazolidin-4-one.(2Z,5Z)-5-(4-硝基亚苄基)-3-N(2-甲氧基苯基)-2-N'(2-甲氧基苯基亚氨基)噻唑烷-4-酮的实验光谱表征、 Hirshfeld表面分析、密度泛函理论/含时密度泛函理论计算及对接研究
Heliyon. 2020 Dec 22;6(12):e05754. doi: 10.1016/j.heliyon.2020.e05754. eCollection 2020 Dec.
2
A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications.关于含氮分子及其生物应用的最新进展综述。
Molecules. 2020 Apr 20;25(8):1909. doi: 10.3390/molecules25081909.
3
The synthetic and therapeutic expedition of isoxazole and its analogs.
异恶唑及其类似物的合成与治疗研究
Med Chem Res. 2018;27(5):1309-1344. doi: 10.1007/s00044-018-2152-6. Epub 2018 Feb 27.
4
Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds.基于 5-硝基呋喃骨架的新型 3,5-二取代异恶唑化合物的设计、合成、抗利什曼原虫和抗真菌生物评价。
Arch Pharm (Weinheim). 2020 Feb;353(2):e1900241. doi: 10.1002/ardp.201900241. Epub 2019 Dec 16.
5
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.含 1,2,3-三氮唑的杂合体作为潜在的抗癌剂:最新进展、作用机制和构效关系。
Eur J Med Chem. 2019 Dec 1;183:111700. doi: 10.1016/j.ejmech.2019.111700. Epub 2019 Sep 16.
6
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.1,2,3-三唑杂合物的抗菌活性的综合评价
Eur J Med Chem. 2019 Apr 15;168:357-372. doi: 10.1016/j.ejmech.2019.02.055. Epub 2019 Feb 22.
7
Triazole derivatives and their antiplasmodial and antimalarial activities.三氮唑衍生物及其抗疟原虫和抗疟疾活性。
Eur J Med Chem. 2019 Mar 15;166:206-223. doi: 10.1016/j.ejmech.2019.01.047. Epub 2019 Jan 25.
8
Exploring the Binding Interaction Mechanism of Taxol in β-Tubulin and Bovine Serum Albumin: A Biophysical Approach.紫杉醇与β-微管蛋白和牛血清白蛋白结合相互作用机制的研究:一种生物物理方法。
Mol Pharm. 2019 Feb 4;16(2):669-681. doi: 10.1021/acs.molpharmaceut.8b00948. Epub 2019 Jan 11.
9
Comparative Binding Analysis of N-Acetylneuraminic Acid in Bovine Serum Albumin and Human α-1 Acid Glycoprotein.牛血清白蛋白和人α-1 酸性糖蛋白中 N-乙酰神经氨酸的比较结合分析。
J Chem Inf Model. 2019 Jan 28;59(1):326-338. doi: 10.1021/acs.jcim.8b00558. Epub 2018 Dec 10.
10
Design, synthesis and anti-Alzheimer's activity of novel 1,2,3-triazole-chromenone carboxamide derivatives.新型 1,2,3-三唑-色满酮酰胺衍生物的设计、合成及抗阿尔茨海默病活性研究。
Bioorg Chem. 2019 Mar;83:391-401. doi: 10.1016/j.bioorg.2018.10.065. Epub 2018 Oct 30.